![Untitled (1920 × 500 px) (4) Untitled (1920 × 500 px) (4)](https://info.allucent.com/hubfs/Untitled%20(1920%20%C3%97%20500%20px)%20(4).png)
Join the A-Team in Montréal for the largest and most recognized meeting of global regulatory affairs professionals.
Connect with Allucent’s regulatory and drug development consulting experts at booth #632 to learn more about how to successfully navigate the ever-changing regulations that are essential to the clinical trial process.Our Allucent A-Team are proud to be joining their fellow panelists for the following sessions.
Wednesday, October 4
08:00–09:15 EDT
Decoding Orphan Drug development: Bridging boundaries and thinking “outside the box”
Session Leader: Luis Rocha, Regulatory Affairs Scientist II
Thursday, October 5
08:00–09:15 EDT
Considerations for Cannabidiol Product Development: The Regulatory Landscape and Safety Concerns.
Presenter: Marcus S. Delatte, VP, Regulatory Strategy
14:00–15:00 EDT
Biosimilar Regulatory Standards in the ICH Regions: Implications for Global Biosimilar Development
Presenter: Antonina Nikolova, VP, CMC
Presenter: Marcus S. Delatte, VP, Regulatory Strategy
15:30 PM–16:30 EDT
Navigating the Unique Complexities of CMC Challenges for Cell Therapies
Presenter: Antonina Nikolova, VP, CMC